Interview with the Chilean Psychiatrist Claudio Naranjo about his clinical experiments in the 60s with Ibogaine; his findings, observations on therapeutic potential and phenomenology, etc.
Interview conducted in Mexico, April 2014
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/ypBoaytF37qb/info/
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico
Thomas Kingsley Brown, PhD
This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at ...Continue Reading →
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/w5HzSJBjBSdf/info/
Notes on Progress in the New Zealand Ibogaine Study
Geoff Noller, PhD
This presentation reports on the first year of progress in the New Zealand observational study of ibogaine treatment outcomes for opioid-dependent persons. Current participants’ data are reviewed and the implications of New Zealand’s ibogaine legislation for research and treatment are discussed.
Dr. Geoff Noller has a background in ...Continue Reading →
Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.
Connect with Rick: http://www.maps.org | firstname.lastname@example.org
Also featuring Alan Steinfeld who assisted in the interviewing of Rick.
Connect with Alan: http://www.newrealities.com | email@example.com